Sarojini, N.B.Sharma, Aastha2011-07-072011-07-072009http://hdl.handle.net/10625/46448Women and health rights activists have looked forward to the drafting of this Bill in light of the unregulated practice of assisted reproductive technologies (ART) and the increasing commercialization and commodification of women’s reproductive tissues. The Bill is based on the ‘National Guidelines for Accreditation, Supervision and Regulation of ART Clinics in India’ and is a welcome and much appreciated step, but unfortunately, it carries on the vestiges of the drawbacks present in the guidelines. This article comments on the draft legislation. Although a positive step, it fails to safeguard the health of women surrogates and their children.Text1 digital file (p. 36-37)enREPRODUCTIVE RIGHTSWOMEN'S HEALTHWOMEN'S RIGHTSASSISTED REPRODUCTIVE TECHNOLOGIESSURROGACYLEGISLATIONREGULATIONIN VITRO FERTILIZATION (IVF)ARTIFICIAL INSEMINATIONJournal Article (peer-reviewed)